Promise of new vascular-disrupting agents balanced with cardiac toxicity: is it time for oncologists to get to know their cardiologists?
Willem J
WJ
van Heeckeren
Shyam
S
Bhakta
Jose
J
Ortiz
Jeff
J
Duerk
Matthew M
MM
Cooney
Afshin
A
Dowlati
Keith
K
McCrae
Scot C
SC
Remick
D000970:Antineoplastic Agents / Q000009:adverse effects*; D042783:Endothelial Cells / Q000187:drug effects*; D006321:Heart / Q000187:drug effects*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D009943:Organophosphorus Compounds / Q000009:adverse effects*
D000970:Antineoplastic Agents; C455219:N-acetylcochinol-O-phosphate; D009943:Organophosphorus Compounds